by Murdoch Children’s Research Institute Credit: Pixabay/CC0 Public Domain A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study. And the findings could spare these children from needing to have a daily injection to boost growth. The...
Tag: <span>Achondroplasia</span>
Post
A controversial dwarfism drug, after clearing pivotal study, heads to the FDA
By DAMIAN GARDE @damiangarde Zayyan Agboatwalla, right, at home with his mother and cousin. Agboatwalla was born with achondroplasia, the most common cause of dwarfism.LAURA MORTON FOR STAT Atreatment for the most common cause of dwarfism met its goal of increasing height in a pivotal study, the drug’s maker said Monday, setting the stage for Food and...